• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Penetration of ceftibuten into middle ear fluid.头孢布烯在中耳液中的渗透情况。
Antimicrob Agents Chemother. 1996 Jun;40(6):1394-6. doi: 10.1128/AAC.40.6.1394.
2
Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.头孢丙烯在血浆和中耳液中的药代动力学:急性中耳炎患儿治疗期间的研究
Paediatr Drugs. 2007;9(2):119-23. doi: 10.2165/00148581-200709020-00005.
3
Loracarbef concentrations in middle ear fluid.氯碳头孢在中耳液中的浓度。
Antimicrob Agents Chemother. 1990 Oct;34(10):2030-1. doi: 10.1128/AAC.34.10.2030.
4
Pharmacokinetics of ceftibuten in children.
Pediatr Infect Dis J. 1995 Jul;14(7 Suppl):S93-101. doi: 10.1097/00006454-199507001-00005.
5
Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media.
Clin Ther. 1996 Sep-Oct;18(5):811-20. doi: 10.1016/s0149-2918(96)80041-5.
6
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.中耳液中抗生素浓度的解读:头孢布烯、头孢克肟和阿奇霉素之间的比较
Br J Clin Pharmacol. 1999 Mar;47(3):267-71. doi: 10.1046/j.1365-2125.1999.00887.x.
7
Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study.头孢布烯治疗流感嗜血杆菌所致急性中耳炎的疗效:一项动物研究。
Ann Otol Rhinol Laryngol. 1993 Mar;102(3 Pt 1):222-6. doi: 10.1177/000348949310200310.
8
Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.索利霉素(CEM - 101)对由不可分型流感嗜血杆菌和肺炎链球菌引起的实验性中耳炎的疗效
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5533-8. doi: 10.1128/AAC.00863-16. Print 2016 Sep.
9
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.阿莫西林、头孢克洛、红霉素 - 磺胺异恶唑及甲氧苄啶 - 磺胺甲恶唑在慢性浆液性中耳炎患者中耳液中的渗透情况。
J Infect Dis. 1982 Jun;145(6):815-21. doi: 10.1093/infdis/145.6.815.
10
Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
J Pharm Sci. 1994 Sep;83(9):1236-40. doi: 10.1002/jps.2600830910.

本文引用的文献

1
Multiple-Dose Pharmacokinetics of Ceftibuten in Healthy Adults and Geriatric Volunteers.
Am J Ther. 1994 Jun;1(1):42-48. doi: 10.1097/00045391-199406000-00008.
2
Parvovirus and neonatal hydrops.
Pediatr Infect Dis J. 1993 Jun;12(6):545. doi: 10.1097/00006454-199306000-00025.
3
Pharmacokinetics and dose proportionality of ceftibuten in men.头孢布烯在男性体内的药代动力学及剂量比例关系
Antimicrob Agents Chemother. 1995 Feb;39(2):359-61. doi: 10.1128/AAC.39.2.359.
4
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.阿莫西林、头孢克洛、红霉素 - 磺胺异恶唑及甲氧苄啶 - 磺胺甲恶唑在慢性浆液性中耳炎患者中耳液中的渗透情况。
J Infect Dis. 1982 Jun;145(6):815-21. doi: 10.1093/infdis/145.6.815.
5
Concentrations of antimicrobial agents in middle ear fluid, saliva and tears.中耳积液、唾液和泪液中抗菌剂的浓度。
Int J Pediatr Otorhinolaryngol. 1981 Dec;3(4):327-34. doi: 10.1016/0165-5876(81)90057-4.
6
Cefotaxime concentrations in otitis media effusions.中耳炎积液中的头孢噻肟浓度。
J Antimicrob Chemother. 1980 Sep;6 Suppl A:131-2. doi: 10.1093/jac/6.suppl_a.131.
7
Antibiotic concentrations in middle ear effusions.
Pediatrics. 1966 Jul;38(1):33-9.
8
Erythromycin concentrations in middle ear exudates.
Pediatrics. 1971 Sep;48(3):417-22.
9
Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics.
J Clin Pharmacol. 1988 Mar;28(3):246-52. doi: 10.1002/j.1552-4604.1988.tb03140.x.
10
Pharmacokinetics and tissue penetration of ceftibuten.头孢布烯的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1990 Jun;34(6):1053-5. doi: 10.1128/AAC.34.6.1053.

头孢布烯在中耳液中的渗透情况。

Penetration of ceftibuten into middle ear fluid.

作者信息

Lin C, Kumari P, Perrotta R J, Reidenberg B E

机构信息

Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.

出版信息

Antimicrob Agents Chemother. 1996 Jun;40(6):1394-6. doi: 10.1128/AAC.40.6.1394.

DOI:10.1128/AAC.40.6.1394
PMID:8726007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC163337/
Abstract

The penetration of ceftibuten, an extended-spectrum oral cephalosporin, into middle ear fluid (MEF) was evaluated in pediatric patients during a course of daily oral doses of 9 mg/kg of body weight for 10 days. Plasma and MEF collected at 2, 4, 6, or 12 h after at least 3 days of dosing were analyzed for ceftibuten by a high-pressure liquid chromatography method, and the data were used to calculate pharmacokinetic parameters. Plasma and MEF had almost identical maximum concentrations (Cmax) of ceftibuten (14 micrograms/ml). These Cmax values in MEF during acute otitis media were well in excess of the MIC for 90% of the isolates of each of four major pathogens in this disease. The time to Cmax was longer in MEF (4 h) than in plasma (2 h). Excellent penetration (71%) of ceftibuten into MEF was observed on the basis of the area under the curve ratio (MEF/plasma). These data clearly indicate that ceftibuten penetrated well into the MEF to yield clinically effective concentrations.

摘要

在儿科患者中,评估了广谱口服头孢菌素头孢布烯在每日口服剂量为9 mg/kg体重、疗程为10天的情况下进入中耳液(MEF)的情况。在给药至少3天后的2、4、6或12小时采集血浆和MEF,采用高压液相色谱法分析其中的头孢布烯,并将数据用于计算药代动力学参数。血浆和MEF中头孢布烯的最大浓度(Cmax)几乎相同(14微克/毫升)。在急性中耳炎期间,MEF中的这些Cmax值远远超过了该疾病四种主要病原体中90%的分离株的最低抑菌浓度(MIC)。MEF达到Cmax的时间(4小时)比血浆(2小时)长。根据曲线下面积比(MEF/血浆),观察到头孢布烯对MEF具有良好的渗透性(71%)。这些数据清楚地表明,头孢布烯能很好地渗透到MEF中,产生临床有效浓度。